Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial

2015 ◽  
Vol 16 (13) ◽  
pp. 1389-1398 ◽  
Author(s):  
Jean Jacques Grob ◽  
Mayur M Amonkar ◽  
Boguslawa Karaszewska ◽  
Jacob Schachter ◽  
Reinhard Dummer ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Combination Therapy ◽  
Randomised Trial ◽  
Health Related Quality ◽  
Open Label ◽  
Phase 3 ◽  
Related Quality ◽  
Health Related

Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study

2016 ◽  
Vol 17 (11) ◽  
pp. 1533-1542 ◽  
Author(s):  
Jaap C Reijneveld ◽  
Martin J B Taphoorn ◽  
Corneel Coens ◽  
Jacoline E C Bromberg ◽  
Warren P Mason ◽  
...  
Keyword(s):  
Quality Of Life ◽  
High Risk ◽  
Low Grade ◽  
Health Related Quality ◽  
Open Label ◽  
Phase 3 ◽  
Open Label Phase ◽  
Related Quality ◽  
Health Related
Sign in / Sign up

Export Citation Format

Share Document